John P. Schmid
Sits on 7 boards. Overboarded · 7 public boards Last updated September 28, 2026
Time on boards
- Boards served
- 7
- Current seats
- 7
- Board service
- 15 years
- Director since
- 2023
15 years of board service in total across 7 boards, counting each seat separately. Longest: AnaptysBio Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
AnaptysBio Inc. August 11, 202692.7%
-
Design Therapeutics Inc. June 10, 202598.9%
-
AnaptysBio Inc. June 15, 202391.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 10, 2026 | BlossomHill Therapeutics Inc. | Open-market purchase | +6,000 | $16.00 | $96,000 |
| Jun 15, 2026 | First Tracks Biotherapeutics Inc. | Option exercise | +6,030 | — | — |
| Jun 15, 2026 | AnaptysBio Inc. | Option exercise | +6,030 | — | — |
| Mar 30, 2026 | AnaptysBio Inc. | Open-market sale | −12,596 | $55.71 | $701,723 |
| Mar 30, 2026 | AnaptysBio Inc. | Open-market sale | −7,527 | $56.70 | $426,781 |
| Mar 30, 2026 | AnaptysBio Inc. | Open-market sale | −522 | $57.40 | $29,963 |
| Dec 23, 2025 | AnaptysBio Inc. | Other | −11,068 | $51.00 | $564,468 |
| Aug 11, 2025 | BridgeBio Oncology Therapeutics Inc. | Option exercise | +30,000 | — | — |
| Jun 15, 2025 | AnaptysBio Inc. | Option exercise | +6,030 | — | — |
| Mar 25, 2025 | AnaptysBio Inc. | Other | +11,068 | $18.18 | $201,216 |
| Jan 13, 2025 | AnaptysBio Inc. | Option exercise | +21,692 | $4.55 | $98,699 |
| Jan 13, 2025 | AnaptysBio Inc. | Option exercise | +20,645 | $8.54 | $176,308 |
| Aug 12, 2024 | Xeris Biopharma Holdings Inc. | Open-market purchase | +4,515 | $2.25 | $10,159 |
| Aug 9, 2024 | Xeris Biopharma Holdings Inc. | Open-market purchase | +4,285 | $2.37 | $10,155 |
| Jun 15, 2024 | AnaptysBio Inc. | Option exercise | +3,900 | — | — |
Questions about John P. Schmid
What boards is John P. Schmid on?
John P. Schmid sits on the boards of AnaptysBio Inc., BlossomHill Therapeutics Inc., BridgeBio Oncology Therapeutics Inc., Design Therapeutics Inc., First Tracks Biotherapeutics Inc., Helix Acquisition Corp. III and Xeris Biopharma Holdings Inc.
How long has John P. Schmid served on boards?
Our records show at least 15 years of board service across 7 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.